Skip to main content

Table 2 Association of NIPBL expression with clinical characteristics of 123 patients with lung adenocarcinoma

From: Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer

characteristics Patients (n = 123), n(%) NIPBL expression P
Low, n (%) High, n (%)
Gender     
Male 81 (65.9) 52 (61.9) 29 (74.4) 0.175
Female 42 (34.1) 32 (38.1) 10 (25.6)  
Age (years)     
<50 37 (30.1) 26 (31.0) 11 (28.2) 0.757
≥50 86 (69.9) 58 (69.0) 28 (71.8)  
Tumor differentiation     
Well differentiated 34 (27.6) 29 (34.5) 5 (12.8) 0.003
Moderately differentiated 47 (38.2) 34 (40.5) 13 (33.4)  
Poorly differentiated 42 (34.2) 21 (25.0) 21 (53.8)  
Lymph node metastasis     
Positive 81 (65.9) 50 (59.5) 31 (79.5) 0.029
Negative 42 (34.1) 34 (40.5) 8 (20.5)  
Disease stage     
I 36 (29.3) 26 (31.0) 10 (25.6) 0.794
II 53 (43.1) 36 (42.9) 17 (43.6)  
III 34 (27.6) 22 (26.1) 12 (30.8)